Chris Pepper

7.0k total citations
154 papers, 4.3k citations indexed

About

Chris Pepper is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Chris Pepper has authored 154 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Genetics, 78 papers in Molecular Biology and 47 papers in Oncology. Recurrent topics in Chris Pepper's work include Chronic Lymphocytic Leukemia Research (87 papers), Cell death mechanisms and regulation (30 papers) and Lymphoma Diagnosis and Treatment (27 papers). Chris Pepper is often cited by papers focused on Chronic Lymphocytic Leukemia Research (87 papers), Cell death mechanisms and regulation (30 papers) and Lymphoma Diagnosis and Treatment (27 papers). Chris Pepper collaborates with scholars based in United Kingdom, United States and Saudi Arabia. Chris Pepper's co-authors include Chris Fegan, Paul Bentley, Timothy J. Hoy, Guy Pratt, Alun Thomas, Paul Brennan, Saman Hewamana, T. G. Hoy, D P Bentley and Elisabeth Walsby and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Chris Pepper

145 papers receiving 4.2k citations

Peers

Countries citing papers authored by Chris Pepper

Since Specialization

Citations

This map shows the geographic impact of Chris Pepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Pepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Pepper more than expected).

Fields of papers citing papers by Chris Pepper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Pepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Pepper. The network helps show where Chris Pepper may publish in the future.

Co-authorship network of co-authors of Chris Pepper

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Pepper. A scholar is included among the top collaborators of Chris Pepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Pepper. Chris Pepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Ajit J. Shah, Ben Forbes, Chris Pepper, Khondaker Miraz Rahman	0
2	93P MDX-124, a novel anti-ANXA1 antibody, has significant anti-cancer activity in preclinical models of osteosarcoma 2025 ·ESMO Open ·(unknown), Siobhan Crichton, Christopher N. Parris, Reda Ibrahem, Haifa Kathrin Al‐Ali, Chris Pepper, Aloka L. Patel	0
3	Design, synthesis and evaluation of pyrrolobenzodiazepine (PBD)-based PROTAC conjugates for the selective degradation of the NF-κB RelA/p65 subunit 2025 ·RSC Medicinal Chemistry ·(unknown), Md. Mahbub Hasan, Andrea Pepper, Simon Mitchell, Khondaker Miraz Rahman, Chris Pepper	0
4	A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo 2024 ·Oncogene ·(unknown), (unknown), (unknown), Chris Pepper, (unknown), Fiona C. Dempsey, (unknown)	16
5	NF-kB and the CLL microenvironment 2023 ·Frontiers in Oncology ·Alice O’Donnell, Chris Pepper, Simon Mitchell, Andrea Pepper	18
6	Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling 2023 ·Cancers ·Evan A. Mulligan, Susan J. Tudhope, Jill V. Hunter, (unknown), Sarah L. Elliott, Geoffrey Summerfield, Jonathan P. Wallis, Chris Pepper, (unknown), Stephany Veuger, Elaine Willmore	4
7	NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma 2023 ·Frontiers in Oncology ·(unknown), (unknown), Heather A. Clark, (unknown), (unknown), John R Jones, Chris Pepper, Andrea Pepper, Simon Mitchell	3
8	<p>Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia Cells</p> 2020 ·International Journal of Nanomedicine ·Suliman A. Alsagaby, Rajendran Vijayakumar, Mariappan Premanathan, Suresh Mickymaray, Wael Alturaiki, Raid Saleem Al-Baradie, Saleh AlGhamdi, Mohammad Azhar Aziz, Fahad A. Alhumaydhi, Faisal A. Alzahrani, Ameen S. S. Alwashmi, Waleed Al Abdulmonem, Naif Khalaf Alharbi, Chris Pepper	27
9	Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients 2015 ·Molecular Oncology ·Kate Simpson, (unknown), Julia W. Grimstead, Robert K. Hills, Chris Pepper, Duncan M. Baird	34
10	Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells 2013 ·Haematologica ·Ryan Wong, Chris Pepper, Paul Brennan, Dirk Nagorsen, Stephen Man, Chris Fegan	69
11	A Novel Tumor Antigen Derived from Enhanced Degradation of Bax Protein in Human Cancers 2011 ·Cancer Research ·(unknown), Kelly L. Miners, Garry Dolton, Chris Pepper, Chris Fegan, Malcolm D. Mason, Stephen Man	14
12	Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression 2011 ·Clinical Cancer Research ·Cláudia Nunes, (unknown), Malcolm D. Mason, Chris Fegan, Stephen Man, Chris Pepper	116
13	SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity 2010 ·Cancer Research ·John A. Hartley, (unknown), (unknown), (unknown), Marie Suggitt, Zhizhi Chen, Stephen J. Gregson, Luke A. Masterson, Arnaud Tiberghien, Janet M. Hartley, Chris Pepper, Thet Thet Lin, Chris Fegan, David E. Thurston, Philip W. Howard	43
14	Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation and De novo Gene Transcription 2010 ·Cancer Research ·Andrea G.S. Buggins, Chris Pepper, Piers Patten, Saman Hewamana, Satyen H. Gohil, (unknown), (unknown), Deborah Yallop, N. Shaun B. Thomas, Ghulam J. Mufti, Chris Fegan, Stephen Devereux	75
15	Quantitative nuclear proteomics reveals new phenotypes altered in lymphoblastoid cells 2009 ·PROTEOMICS - CLINICAL APPLICATIONS ·Paul Brennan, (unknown), Mathew Clement, Saman Hewamana, (unknown), Peter Giles, Chris Fegan, Chris Pepper, Ian A. Brewis	9
16	Sub‐millimolar concentration of the novel phenol‐based compound, 2‐hydroxy benzoate zinc, induces apoptosis in human HT‐1080 fibrosarcoma cells 2009 ·Cell Proliferation ·Jassem G. Mahdi, Chris Pepper, (unknown), Ali Jassem Mahdi, I. D. Bowen	7
17	IgM multiple myeloma: a diagnostic challenge in a patient with coexisting chronic lymphocytic leukaemia 2008 ·International Journal of Hematology ·Saman Hewamana, Chris Pepper, (unknown), (unknown), Steven Knapper	2
18	Highly purified CD38⁺ sub‐populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38⁻ sub‐populations derived from the same chronic lymphocytic leukaemia patient 2008 ·British Journal of Haematology ·Thet Thet Lin, Saman Hewamana, (unknown), (unknown), (unknown), Guy Pratt, Duncan M. Baird, Chris Fegan, Chris Pepper	14
19	Bryostatin Induces Protein Kinase C Modulation, Mcl-1 Up-Regulation and Phosphorylation of Bcl-2 Resulting in Cellular Differentiation and Resistance to Drug-induced Apoptosis in B-cell Chronic Lymphocytic Leukemia Cells 2004 ·Leukemia & lymphoma ·Alun Thomas, Chris Pepper, Timothy J. Hoy, Paul Bentley	22
20	Chlorambucil resistance in B‐cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl‐2‐expressing subclones 1999 ·British Journal of Haematology ·Chris Pepper, Alun Thomas, T. G. Hoy, Paul Bentley	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact